We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$525B
AUM Growth
+$91.7B
Cap. Flow
+$84.3B
Cap. Flow %
16.06%
Top 10 Hldgs %
21.31%
Holding
3,738
New
263
Increased
2,391
Reduced
822
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Financials 10.66%
3 Healthcare 9.68%
4 Consumer Discretionary 8.35%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZ
3601
DELISTED
Enzo Biochem, Inc.
ENZ
$14.7K ﹤0.01%
13,471
USBC
3602
USBC Inc
USBC
$119M
$14.4K ﹤0.01%
876
VATE icon
3603
INNOVATE Corp
VATE
$106M
$14K ﹤0.01%
2,312
-3,046
-57% -$20.1K
ZVIA icon
3604
Zevia
ZVIA
$118M
$13.5K ﹤0.01%
20,011
-56,995
-74% -$52.7K
STRM
3605
DELISTED
Streamline Health Solutions
STRM
$13.4K ﹤0.01%
1,935
HYPR icon
3606
Hyperfine
HYPR
$88.4M
$12.4K ﹤0.01%
14,647
AHT
3607
Ashford Hospitality Trust
AHT
$20.8M
$12.3K ﹤0.01%
1,267
+21
+2% +$252
XLO icon
3608
Xilio Therapeutics
XLO
$59.8M
$11.3K ﹤0.01%
852
INAB icon
3609
IN8bio
INAB
$10.3M
$11.1K ﹤0.01%
437
ALGS icon
3610
Aligos Therapeutics
ALGS
$26.3M
$11K ﹤0.01%
1,255
WKSP icon
3611
Worksport
WKSP
$8.74M
$10.8K ﹤0.01%
1,392
SDOT icon
3612
Sadot Group
SDOT
$15.1M
$10.6K ﹤0.01%
14
DARE icon
3613
Dare Bioscience
DARE
$17.4M
$10.3K ﹤0.01%
2,544
AUGX
3614
DELISTED
Augmedix, Inc. Common Stock
AUGX
$10.2K ﹤0.01%
11,589
LODE icon
3615
Comstock
LODE
$206M
$9.83K ﹤0.01%
5,993
VNRX icon
3616
VolitionRx Ltd
VNRX
$9.31M
$9.37K ﹤0.01%
774
+5
+0.7% +$73
CLNN icon
3617
Clene
CLNN
$60.3M
$9.15K ﹤0.01%
1,285
PRST
3618
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$8.56K ﹤0.01%
122,265
-6,491
-5% -$947
QNCX icon
3619
Quince Therapeutics
QNCX
$21.5M
$8.26K ﹤0.01%
55
SPRB
3620
Spruce Biosciences
SPRB
$114M
$7.92K ﹤0.01%
204
MRDB
3621
DELISTED
MariaDB plc
MRDB
$7.38K ﹤0.01%
13,835
HYPD
3622
Hyperion DeFi Inc
HYPD
$35.5M
$7.34K ﹤0.01%
155
-794
-84% -$46K
QUBT icon
3623
Quantum Computing Inc
QUBT
$1.65B
$5.37K ﹤0.01%
10,691
+475
+5% +$355
ARTNA icon
3624
Artesian Resources
ARTNA
$360M
-25,345
Closed -$941K
FRMM
3625
Forum Markets
FRMM
$69.9M
-1,836
Closed -$42.8K

Similar funds

Charles Schwab's Q2 2024 Portfolio in Review

As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.

  • Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
  • Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
  • Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
  • Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
  • Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
  • Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
  • Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.